Literature DB >> 3004918

Regulation of thyroxine 5'-deiodinase by thyroid hormones and activators of protein kinase C in GH4C1 cells.

R J Koenig.   

Abstract

The regulation of T4 5'-deiodinase activity was studied in cultured GH4C1 cells. Enzyme activity was measured in cell sonicates as the release of radioiodide from [125I]T4. Enzyme activity was stimulated 2- to 3-fold by hypothyroid serum and activators of protein kinase C, such as TRH and phorbol esters. The hypothyroid serum effect was maximal by 3 h, whereas TRH and phorbol esters required 6 h to achieve a maximal effect. The hypothyroid serum effect was gone within 4 h of returning the cells to control medium. In contrast, the TRH and phorbol ester effects persisted 24-48 h after removal of those agents. Both T4 and rT3 were at least as potent as T3 in blocking the effect of hypothyroid serum. The stimulation of 5'-deiodinase induced by hypothyroid serum was additive with that induced by kinase C activators. Trifluoperazine blocked the effect of TRH and phorbol esters, but not that of hypothyroid serum. It is concluded that stimulation of 5'-deiodinase activity can occur by at least two independent mechanisms: one involving hypothyroidism and another involving activation of protein kinase C. The relative potencies of various iodothyronines for abolishing the hypothyroid effect differ markedly from the relative binding affinities of these agents for the nuclear T3 receptor, suggesting that this thyroid hormone effect may not be mediated by the classical nuclear thyroid hormone receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3004918     DOI: 10.1210/endo-118-4-1491

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  4 in total

1.  Type 2 iodothyronine deiodinase in rat pituitary tumor cells is inactivated in proteasomes.

Authors:  J Steinsapir; J Harney; P R Larsen
Journal:  J Clin Invest       Date:  1998-12-01       Impact factor: 14.808

2.  Type 2 Iodothyronine Deiodinase Activity Is Required for Rapid Stimulation of PI3K by Thyroxine in Human Umbilical Vein Endothelial Cells.

Authors:  Tomoyuki Aoki; Katsuhiko Tsunekawa; Osamu Araki; Takayuki Ogiwara; Makoto Nara; Hiroyuki Sumino; Takao Kimura; Masami Murakami
Journal:  Endocrinology       Date:  2015-08-18       Impact factor: 4.736

3.  Rapid alteration in circulating free thyroxine modulates pituitary type II 5' deiodinase and basal thyrotropin secretion in the rat.

Authors:  S L Abend; S L Fang; S Alex; L E Braverman; J L Leonard
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

Review 4.  Deiodinases and Cancer.

Authors:  Annarita Nappi; Maria Angela De Stefano; Monica Dentice; Domenico Salvatore
Journal:  Endocrinology       Date:  2021-04-01       Impact factor: 4.736

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.